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Introduction
The goal of this project was to find a feline lymphokine 
exhibiting T-cell suppression. Many lymphokines have been found 
in nouse, rat, and various lynphomas (1-8) that can supress T- 
cell growth and IL-2 production, however; little has been 
published concerning analogous feline factors. The aim of the 
project has thus been to isolate a factor from FeLV infected cats 
which exhibited T-cell suppressive activity.
In the feline leukemia virus (FeLV) system, several reports 
of suppression by the virus have been reported (11-13). In the 
experiments performed in these reports, response to ConA was 
shown to be suppressed by factors derived from the virus. UV 
inactivated FeLV virions themselves and a viral envelope protein, 
pl5E, noncompetively inhibit mouse splenocytes' production of IL- 
2 (12,13).
In work done before I came to Dr. Tompkins' lab, a 
nondialyzable factor (obtained from ConA blastogeneses of FeLV 
infected cats) was shown to suppress IL-2 activity. When the 
factor was run on a polyacrylamide electrophoresis gel a new 80kd 
protein was seen. This result indicated that the factor 
suppressing IL-2 activity was a new factor and not pl5E.
It will be interesting to see how the feline factor fits into 
the suppression picture. If indeed FeLV is activating the 
production of the factor or increasing the sensitivity to the 
factor, perhaps we will be able to better understand how a 
retrovirus can immunosuppress its host.
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Materials and Methods;
Materials
RPMI-1640 (obtained form Gibco)
S-MEM: suspension MEM (no Ca2+)
CPSR-2: serum substitute (obtained from Sigma)
SF-MEM : 10% CPSR-2 in MEM
Dilution Media: RPMI-1640 + L-glut + antibiotics, penicillin and
streptamycin 
E-MEM (Eagle MEM from Gibco)
Concanavalin A stock: lOug/ml obtained from Sigma
A23187 stock: 20ug/ml
PMA stock: lOug/ml in DMSO
PMA stands for Phorbol 12-Myristate 13-Acetate 
Percoll obtained from Pharmacia 
Ficol 7.93%
Hypaque from Sigma 
Saline .85%
Animals
Hen and balb/c mice 
cats: normal (control)
FeLV infected (obtained from Ohio State)
Methods
Preparation of Mouse Spleen Cells
Balb/c or Hen mouse spleens were broken apart by passing them 
through a 100 mesh screen with a glass pestle into a small 
amount of S-MEM. The spleen suspension was then layered onto a
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4:1 FicoltHypaque solution and centrifuged at 400xg for 30min. 
Spleen cells were removed from the flcol-S-MEM interface. The 
cells were then washed three times with fresh S-MEN and 
resuspended in sf-NEM.
Spleen Cell Blastoaenesis
One milliliter of sf-MEM suspended spleen cells containing at 
least 5x10° cells were used for each trial. With ConA trials (ie 
trials with ConA as the mitogen) .5ug ConA/ml cell suspension was 
used to blast the cells. With A2/PMA trials .5ug A2 and .006ug 
of PMA (a phorbol ester) were used to blast the cells. Cell 
suspensions were then incubated for 24-72hrs (48hrs worked well) 
at 37°C and 5% CO_. The cells were then centrifuged down and 
1/2 of the supernatant was collected. The cells were then 
resuspended in the remaining fluid and pulsed with 2uCi H- 
Thymidine for 3-4hrs. The solution was then harvested on a 
millipore multipore filtration device using .2u glass filters. 
After the filters had dried, the filters were placed in scint 
vials with 5ml of Econoflur scintillation cocktail and counted.
Inhibition Assay
After preparing spleen cells, the cells were centrifuged down 
£
and 5x10 cells/assay were incubated for one hour in lOOul of 
crude, previously collected supernatants from Spleen Cell 
Blastogeneses. The cells were then washed twice with fresh S- 
KEM, resuspended in sf-MEM, and run through a Spleen Blasto- 
genesis assay.
Feline PBL Isolation: Percoll Separation of FBLs
To freshly drawn blood an equal volume of S-MEM was added 
(inorder to dilute out the EDTA added when bleeding). To 15ml 
centrifuge tubes, 4ml of 62% percoll was added to form a bottom 
layer and 4ml of 43% percoll, a top layer. 4ml of diluted blood 
was then layered on top of the 43% and the layered cells were 
centrifuged at 400xg for 5min. The plasma was taken off along 
with the platlets and 3ml of S-MEM was layered on the 43% to 
replace the plasma. The tubes were then recentrifuged at 600xg 
for 15min. Lymphocytes were removed from the interface between 
the 62% and the 43% layers, washed free of percoll, and 
resuspended in sf-MEM.
PBL Blastoaenesis
Feline PBL's — 5x10° in 1ml—  were added to culture 
centrifuge tubes and blasted with ConA or A2/PMA. ConA was used 
at .5ug/ml of cells and A2/PMA, at .5ug/ml and .006ug/ml 
respectively. Cell suspensions were incubated (37° C;5I CO.) for 
18hrs in preparation for IL2 assays or 48hrs for the preparation 
of suppressor supernatants. At the end of the incubation the 
cell suspensions were centrifuged down and the supernatants were 
collected.
IL2 Assay
Samples and controls were serially diluted by factors of 2 
with dilution media. lOOul of each dilution were added in
4duplicate to lOOul of CTL cell suspension containing 1x10 cells 
in 96well plates. The plates were then incubated for 54hrs at 
37°C and 5%C02. The cells were pulsed with 2uCi 3H-Thymidine for
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18hrs, harvested with a microharvester, and counted in a 
scintillation counter.
Suppression Assay
Supernatants collected in 48hr PBL blastogeneses were incu­
bated for one hour with freshly collected PBLs in the proportion 
of lOOul of crude supernatant per 5xl06 cells. The cells were 
then washed twice with fresh S-MEM, and run in a 18hr PBL blasto- 
genesis. Suppression activity was seen by comparing IL-2 levels 
of these cells to blasted cells not exposed to the supernatants.
Discussion
In my first semester, supernatants taken from FeLV infected, 
feline PBL's (blasted with ConA) were run on a PAGE (run by Nr. 
Eurell). The results indicated that a new protein of 
approximately 80kd appeared after ConA blasting, working on the 
assumption that this was the protein causing the growth 
inhibition, a literature search was conducted. IDS (inhibitor of 
DNA synthesis), a 80kd glycoprotein, was found (1).
The original work on IDS was conducted on lymph node cells 
taken from inbred male Lewis rats. However, it was decided that 
mouse spleen cells would be used. These cells are similar to 
lymph node cells in function (straining body fluids of foreign 
antigens) and easier to isolate. Lewis rats were not immediately 
available, whereas two strains of mice were. Also, the isolation 
of spleen cells was similar to the isolation of feline PBL's 
which would be done later. In addition, information on many 
mouse, rat, and lymphoma derived suppressive factors was
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available, thus a factor isolated from the spleen cells could be 
compared to the feline factor and to previously documented 
research. Unfortunately, the supernatants taken from the mouse 
spleen cell blastogenesis assays had no affect on cat PBL's.
Work on mouse spleen cells thus shifted to feline PBLs solely. 
Supernatants were collected from FeLV infected PBL blastogeneses 
and run in suppression assays. Eventually inhibitory activity 
was found. Suprisingly though, the activity in the new 
supernatants may be different than the activity which engendered 
the project. In the original assays of suppressor activity, 
suppression was exhibited as a prolonged prozone. In the new 
activity suppression results in drastically lowered IL-2 activity 
levels over a wide range of dilutions.
The activities may still be the same. The original activity 
may merely result from a lower concentration of suppressor. The 
assay conditions have also changed slightly. The original assay 
used BSA to stabilize the media; whereas the new assay used a 
serum substitute. The serum substitute contained no protein and 
thus made potential isolation of a factor cleaner, but the lack 
of albumin may affect the production of the suppressor factor in 
some way.
Exactly what is happening is not yet clear. When the 
rupernatants were run on an HPLC (size exclusion column), no 
difference was seen between control and suppressive supernatants 
— again unlike the original suppressive trials in which an 80kd 
was seen. Several possibilities exist. First, the factor
suppressing may act in exceedingly low concentration — too low 
for the HPLC to detect. Second, the factor may be present but 
hiding behind a peak on the 'spectrum'. Third, the protein may 
be unstable for long periods of time even at 4°C.
The first possibility is unlikely. The HPLC was run at 
maximum sensitivity and it should easily have detected any 
protein at concentrations of lOng/ml or better. The protein may 
still be present, however; since suppressors have a reputation 
for high activity at extremely low concentrations.
To check the second possibility an isoelectric focusing will 
be performed on the protein with in the next few weeks. If the 
supressor factor is indeed hiding behind a background peak in the 
HPLC size exclusion spectrum, the isoelectric focusing should be 
able to separate the factor from the background.
The 80kd protein may not even be present. Instead the 
suppressive activity of the supernatant may be caused by pl5E. 
Since pl5E is a 15kd protein, suppression could result without a 
protein greater than 20kd present on the gel. The activity of 
the protein is also similiar to that of the reported activity of 
pl5E (11-13).
More work will need to be done to conclusively show either 
that FeLV sheds plSE when ConA blasted or whether an 80kd protein 
is indeed present which can suppress IL-2 activity.
Conclusion
It has been shown that retroviruses can inhibit IL-2 
production (10-13). Although it is likely that 80kd protein is
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of cellular origin, the FeLV has several open reading frames of 
unknown function. One could be the 80kd protein.
If the 80kd protein is causing immunosuppression and is 
induced in someway by the FeLV virus, the mechanism by which it 
suppresses T-cells becomes an important question. A virus 
derived factor's production could be stimulated by mechanisms 
similiar to those used by FeLV and other oncogenic retroviruses 
in the synthesis of oncogene products. If the 80kd protein is 
encoded by the virus it may have an analog in the normal cat 
genome. The activity of the protein may be different for the 
viral gene product and the cellular one. Viral promoters may 
also be driving overexpression of the gene coding for the 
protein.
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Name of 
SuDDressor
Cell type 
Isolated from
Mitogen
used Reference
IDS Rat lymphnode cells ConA J.Exp.Med,vl50,p622
U937 factor U937 cell line PHA JI,Vl38,pl97
STIF Rat spleen cells ConA JI,Vl34,pl019
Contra-IL2 AS-9 CS (Tcell hyb) PHA,ConA JI,vl36,p3298
SER Human blood plasma JI,Vl35,p355
SISS-T Human PBL's ConA JI,Vl26,pll85
TGF-Al Human T-cells PHA JI,vl39,p2977
i-INF Human T-cells PHA JI,V139,p2977
Oncostatln M Human T-cells FHA JI,v!39,p2977
SIRS House Spleen Cells ConA JI,V131,p2848
mO-sf Mouse Macrophages SIRS JI,V127|p!828
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Table II: Abreviations
PBL: Periferal Blood Lymphocyte
CTL: Cytotoxic T-Lymphocte (an IL-2 dependent cell line)
IDS: Inhibitor of DNA Synthesis
STIF: Stimulated T-cell derived Inhibitory Factor
SER: Suppressive E Receptor factor
SISS: Soluble Immune Suppressor Supernatant
a-IFN: A-Interferon
TGF-Al: Transforming Growth Factor-Al
*:» i* Soluble Immune Response Suppressor
Mi)-sn Nonspecific Suppressor Factor
FuLV: Feline Leukemia Virus
ConA: Concanavalin A (a mitogenic lectin)
PMA: Phorbol 12-Myristate 13-Acetate
A2: same as A23187 (a calcium ionophore)
MEN: Minimal Essential Medium
2+S-: without Ca , also called suspension medium 
E-: Eagle MEM
SF: MEM with serum substitute added
CPSR: Controled Process Serum Replacement
IL-2: Interleukin 2
BSA: Bovine Serum Albumin
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Graph I: Action of Mouse Supernatants on Feline PBL's
This graph shows the inactivity of the mouse derived 
supernatants on the Cat PBL's. The low response of Rat IL-2 on 
the Cat PBL's at high concentrations of IL-2 is due to prozone 
phenomena. Briefly, this effect results from the binding of IL-2 
to low affinity, IL-2 receptors. Unlike the binding of IL-2 to 
the high affinity receptors which cause the cell to divide, low 
affinity binding causes suppression of T-cell proliferation 
(Kumar, et al. JI vl38, pl485-1493).
Graph II: Suppression of IL-2 Activity
In this suppression experiment, cat supernatants from a 48hr 
blastogenesis of a FeLV infected PBL resulted in the complete 
suppression of another FeLV infected cat PBL's ability to produce 
IL-2. Rat IL-2 is included to show maximal response by the CTL's 
used to assay for IL-2. The ConA control indicates the response 
(IL-2 production) of feline PBL's (blasted with ConA) without 
exposure to the supernatant. The MEN control indicates the 
minimal (background) IL-2 production as measured by CTL growth. 
The ConA run indicates the IL-2 production of the ConA blasted 
cells after exposure to the supernatant for one hour. The 
vertical scale is in counts per minute.
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